Advanced Enzyme Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Un-Audited Standalone ....
ADVENZYMES · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Advanced Enzyme Technologies has informed exchanges that its Board of Directors will meet on Wednesday, November 12, 2025 to consider and approve the Un-audited Financial Results (both Standalone and Consolidated) for the quarter and half year ended September 30, 2025. The company also stated that the Trading Window for dealing in its securities will remain closed until November 14, 2025, in line with insider trading norms ahead of the results announcement. The filing was signed by Sanjay Basantani, Company Secretary and Head – Legal.
This is a routine regulatory disclosure and does not by itself move the stock. Investors should watch the November 12 results for actual revenue, profit and margin trends, which will set the next directional cue for the share price.